A pioneering study from Seoul National University shows promise in treating male infertility by injecting PIN1 protein-loaded nanoparticles into the testicles, successfully boosting sperm production in infertile mice.
In France, about one in eight couples seeks help for conception difficulties. In 75% of cases, infertility stems from male, female, or combined factors. For men, spermatogenesis abnormalities—particularly oligospermia, defined as fewer than 30 million sperm per ml—are the leading cause.
Researchers at Seoul National University developed a targeted approach to reactivate sperm production. Initial mouse trials yielded impressive results: previously infertile males quickly fathered offspring at rates comparable to healthy peers. Findings are detailed in the peer-reviewed journal ACS Nano.
Much like the blood-brain barrier safeguards neural tissue, the blood-testis barrier shields sperm-producing cells from blood-borne toxins. Damage to this barrier disrupts spermatogenesis.
The protein PIN1 is crucial for maintaining this barrier. The team encapsulated PIN1 in biocompatible silk fibroin nanoparticles coated with lipids, then injected them directly into the testicles of mice genetically engineered to lack PIN1—resulting in shrunken testes and insufficient sperm.
Treated mice saw their testes return to normal size and weight. Sperm counts rose significantly, though still about 50% below healthy levels—yet fertility was unaffected. Over months, these males sired nearly as many pups as untreated fertile controls.
In contrast, untreated infertile controls remained sterile.
While exciting, human applications require further animal studies before clinical trials. This work highlights nanoparticles' potential in reproductive medicine.
